Influence of fundectomyand intraperitoneal or intragastric administration of apelin on apoptosis, mitosis, and DNA repair enzyme OGG1,2 expression in adult rats gastrointestinal tract and pancreas

Journal of Physiology and Pharmacology

Volumn 64, Issue 4, 2013, Pages 423-428

  Antushevich, Hanna ^a   Pawlina, B ^a   Kapica, M ^b   Krawczynska, A ^a   Herman, A P ^a   Kuwahara, A ^c   Kato, I ^d   Zabielski, R ^e  

^a KIELANOWSKI INSTITUTE OF ANIMAL PHYSIOLOGY AND NUTRITION   (Poland)

^b UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

^c UNIVERSITY OF SHIZUOKA   (Japan)

^d HOKURIKU UNIVERSITY   (Japan)

^e WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Apelin; Apoptosis; Cell proliferation; DNA damage; Fundectomy; Mitosis; OGG1,2

Indexed keywords

APELIN; APELIN 13; KI 67 ANTIGEN; PLACEBO; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; SODIUM CHLORIDE; UNCLASSIFIED DRUG; APELIN-13 PEPTIDE; CASPASE 3; DNA GLYCOSYLTRANSFERASE; OGG1 PROTEIN, RAT; SIGNAL PEPTIDE; APELIN 13 PEPTIDE;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL METABOLISM; COLON; CONTROLLED STUDY; DNA DAMAGE; DUODENUM; FEEDING; FUNDECTOMY; GASTROINTESTINAL TRACT; IMMUNOFLUORESCENCE; INTESTINE EPITHELIUM; JEJUNUM; MALE; MITOSIS; MITOSIS INDEX; NONHUMAN; PANCREAS; PROTEIN EXPRESSION; RAT; STOMACH EPITHELIUM; STOMACH FUNDUS; STOMACH SURGERY; TURNOVER TIME; UPPER GASTROINTESTINAL TRACT; WISTAR RAT; ANIMAL; CYTOLOGY; DRUG ADMINISTRATION ROUTE; DRUG EFFECTS; INTESTINE MUCOSA; METABOLISM; SURGERY; DRUG EFFECT;

ANIMALS; APOPTOSIS; CASPASE 3; DNA DAMAGE; DNA GLYCOSYLASES; DRUG ADMINISTRATION ROUTES; GASTROINTESTINAL TRACT; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTESTINAL MUCOSA; KI-67 ANTIGEN; MALE; MITOSIS; PANCREAS; RATS; RATS, WISTAR;

EID: 84884959084     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou M. X, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998; 251: 471-476.
2. Lee DK, Cheng R, Nguyen T, et al. Characterization of apelin, the ligand for the APJ receptor. J Neurochem 2000; 74: 34-41.
3. De Mota, Lenkei N, Llorens-Cortes C. Cloning, pharmacological characterization and brain distribution of the rat apelin receptor. Neuroendocrinology 2000; 72: 400-407.
4. Higuchi K, Masaki T, Gotoh K, et al. Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice. Endocrinology 2007; 148: 2690-2697.
5. Kawamata Y, Habata Y, Fukusumi S, et al. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 2001; 1538: 162-171.
6. O'Dowd BF, Heiber M, Chan A, et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993; 136: 355-360.
7. Foldes G, Horkay F, Szokodi I, et al. Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J Biol Chem 2000; 275: 21061-21067.
8. Medhurst AD, Jennings CA, Robbins MJ, et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem 2003; 84: 1162-1172.
9. Kapica M, Jankowska A, Antushevich H, et al. The effect of exogenous apelin on the secretion of pancreatic juice in anaesthetized rats. J Physiol Pharmacol 2012; 63: 53-60.
10. Susaki E, Wang G, Cao G, Wang HQ, Englander EW, Greeley GH. Apelin cells in the rat stomach. Regul Pept 2005; 129: 37-41.
11. Wang G, Kundu R, Han S, et al. Ontogeny of apelin and its receptor in the rodent gastrointestinal tract. Regul Pept 2009; 158: 32-39.
12. Wang G, Anini Y, Wei W, et al. Apelin, a new enteric peptide: localization in the gastrointestinal tract, ontogeny, and stimulation of gastric cell proliferation and of cholecystokinin secretion. Endocrinology 2004; 145: 1342-1348.
13. Taheri S, Murphy K, Cohen M, Sujkovic E, Kennedy A, Dhillo W. The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem Biophys Res Commun 2002; 291: 1208-1212.
14. Castan-Laurell I, Dray C, Attane C, Duparc T, Knauf C, Valet P. Apelin, diabetes, and obesity. Endocrine 2011; 40: 1-9.
15. Ishida J, Hashimoto T, Hashimoto Y, et al. Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem 2004; 279: 26274-26279.
16. Tatemoto K, Takayama K, Zou MX, et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001; 99: 87-92.
17. Wang G, Anini Y, Wei W, et al. Apelin, a new enteric peptide: localization in the gastrointestinal tract, ontogeny, and stimulation of gastric cell proliferation and of cholecystokinin secretion. Endocrinology 2004; 145: 1342-1348.
18. Rayalam S, Della-Fera MA, Kasser T, Warren W, Baile CA. Emerging role of apelin as a therapeutic target in cancer: a patent review recent pat anticancer Drug Discov 2011; 6: 367-272.
19. Tang SY, Xie H, Yuan LQ, et al. Apelin stimulates proliferation and suppresses apoptosis of mouse osteoblastic cell line MC3T3-E1 via JNK and PI3-K/Akt signaling pathways. Peptides 2007; 28: 708-718.
20. Matyjek R, Kapica M, Puzio I, Babelewska M, Zabielski R. The effect of fundectomy on pancreatic secretion in anaesthetized rats. J Physiol Pharmacol 2004; 55(Suppl. 2): 69-75.
21. Kapica M, Puzio I, Kato I, Kuwahara A, Zabielski R. Role of feed-regulating peptides on pancreatic exocrine secretion. J Physiol Pharmacol 2008; 59(Suppl. 2): 145-159.
22. Szczepanska-Sadowska E, Cudnoch-Jedrzejewska A, Ufnal M, Zera T. Brain and cardiovascular diseases: common neurogenic background of cardiovascular, metabolic and inflammatory diseases. J Physiol Pharmacol 2010; 61: 509-521.
23. Tarczyk Z, Trzebski A. Fizjologia czlowieka z elementami fizjologii stosowanej i klinicznej. Warszawa, Wydawnictwo Lekarskie PZWL, 2001.
24. Han S, Wang G, Qi X, Lee HM, Englander EW, Greeley GH Jr. A possible role for hypoxia-induced apelin expression in enteric cell proliferation. Am J Physiol Regul Integr Comp Physiol 2008; 294: 1832-1839.
25. Li F, Li L, Qin X, et al. Apelin-induced vascular smooth muscle cell proliferation: the regulation of cyclin D1. Front Biosci 2008; 13: 3786-3792.
26. Liu C, Su T, Li F, et al. PI3K/Akt signaling transduction pathway is involved in rat vascular smooth muscle cell proliferation induced by apelin-13. Acta Biochim Biophys Sin 2010; 42: 396-402.
27. Berta J, Kenessey I, Dobos J, et al. Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis. J Thorac Oncol 2010; 5: 1120-1129.
28. Kasai A, Ishimaru Y, Kinjo T, et al. Apelin is a crucial factor for hypoxia-induced retinal angiogenesis. Arterioscler Thromb Vasc Biol 2010; 30: 2182-2187.
29. Cui RR, Mao DA, Yi L, et al. Apelin suppresses apoptosis of human vascular smooth muscle cells via APJ/PI3-K/Akt signaling pathways. Amino Acids 2010; 39: 1193-1200.
30. Zhang Z, Yu B, Tao GZ. Apelin protects against cardiomyocyte apoptosis induced by glucose deprivation. Chin Med J (Engl) 2009; 122: 2360-2365.
31. Xie H, Yuan LQ, Luo XH, et al. Apelin suppresses apoptosis of human osteoblasts. Apoptosis 2007; 12: 247-254.
32. Zeng X, Yu SP, Taylor T, et al. Protective effect of apelin on cultured rat bone marrow mesenchymal stem cells against apoptosis. Stem Cell Res 2012; 8: 357-367.